• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.29% Nasdaq Down 3.25%

    OXiGENE, Inc. (OXGN)

    -NasdaqCM
    0.61 Down 0.01(1.60%) Feb 5, 3:59PM EST
    Prev Close:0.62
    Open:0.61
    Bid:0.41 x 1000
    Ask:0.99 x 400
    1y Target Est:4.00
    Beta:1.39042
    Next Earnings Date:N/A
    Day's Range:0.60 - 0.62
    52wk Range:0.49 - 1.97
    Volume:19,932
    Avg Vol (3m):173,321
    Market Cap:16.15M
    P/E (ttm):N/A
    EPS (ttm):-0.52
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for OXGN

    Comparison

    Symbol% ChgMkt Cap
    OXGNDown 1.60%16.15M
    AZNDown 1.44%75.92B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.53
    Quarterly EPS Est (Dec-15) :-0.14
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    OXiGENE, Inc., a biopharmaceutical company, focuses on the development of vascular disrupting agents to treat cancer in the United States. Its principal clinical stage product includes fosbretabulin tromethamine, a reversible tubulin binding agent... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback